1. Home
  2. SAMG vs IBIO Comparison

SAMG vs IBIO Comparison

Compare SAMG & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$9.76

Market Cap

79.3M

Sector

Finance

ML Signal

HOLD

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$1.37

Market Cap

83.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
IBIO
Founded
2002
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.3M
83.5M
IPO Year
2012
2009

Fundamental Metrics

Financial Performance
Metric
SAMG
IBIO
Price
$9.76
$1.37
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.75
AVG Volume (30 Days)
67.4K
1.1M
Earning Date
05-01-2026
05-14-2026
Dividend Yield
6.36%
N/A
EPS Growth
N/A
73.08
EPS
0.03
N/A
Revenue
$91,358,000.00
N/A
Revenue This Year
$8.99
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$332.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.94
$0.56
52 Week High
$16.97
$3.82

Technical Indicators

Market Signals
Indicator
SAMG
IBIO
Relative Strength Index (RSI) 37.00 32.61
Support Level N/A $0.97
Resistance Level $11.61 $1.80
Average True Range (ATR) 0.41 0.12
MACD -0.01 -0.02
Stochastic Oscillator 3.34 10.24

Price Performance

Historical Comparison
SAMG
IBIO

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income, and cash, as well as non-traditional investment strategies including hedge funds, private equity funds, real estate, and commodities. The firm offers a full suite of complementary and customized family office services for families seeking comprehensive oversight of their financial affairs. The company derives revenues from Managed accounts, Silvercrest funds, Tax and family office services, and Fund administration. The firm generates the majority of its revenue from Managed Accounts.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: